Burning Rock Forms Diagnostic Partnership with Illumina

In August, Burning Rock, a Guangzhou oncology diagnostics company, partnered with sequencing firm Illumina to develop user-friendly molecular diagnostic kits for the China oncology market. Burning Rock will provide its nucleic acid extraction, library preparation, and data analysis software; Illumina will provide its next-generation sequencing (NGS) instrument components and related reagents. More detialis.... Stock Symbol: (NSDQ: ILMN) Share this with colleagues: // //